242 related articles for article (PubMed ID: 20691195)
1. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke.
Iaci JF; Ganguly A; Finklestein SP; Parry TJ; Ren J; Saha S; Sietsma DK; Srinivas M; Vecchione AM; Caggiano AO
Neuropharmacology; 2010 Dec; 59(7-8):640-9. PubMed ID: 20691195
[TBL] [Abstract][Full Text] [Related]
2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia.
Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R
Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753
[TBL] [Abstract][Full Text] [Related]
4. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
5. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
Vakili A; Zahedi-Khorasani M
Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
Zhang Y; Feustel PJ; Kimelberg HK
Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
[TBL] [Abstract][Full Text] [Related]
7. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke.
Xu Z; Croslan DR; Harris AE; Ford GD; Ford BD
J Cereb Blood Flow Metab; 2006 Apr; 26(4):527-35. PubMed ID: 16136057
[TBL] [Abstract][Full Text] [Related]
8. Strategies to improve post-stroke behavioral recovery in aged subjects.
Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
[TBL] [Abstract][Full Text] [Related]
9. Post-stroke pharmacological intervention: promoting brain recovery from injury in the future.
Barone FC
Neuropharmacology; 2010 Dec; 59(7-8):650-3. PubMed ID: 20804774
[No Abstract] [Full Text] [Related]
10. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression.
Xu Z; Ford GD; Croslan DR; Jiang J; Gates A; Allen R; Ford BD
Neurobiol Dis; 2005 Aug; 19(3):461-70. PubMed ID: 16023588
[TBL] [Abstract][Full Text] [Related]
13. An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats.
Iaci JF; Parry TJ; Huang Z; Pavlopoulos E; Finklestein SP; Ren J; Caggiano A
J Neurosci Res; 2016 Mar; 94(3):253-65. PubMed ID: 26660233
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
[TBL] [Abstract][Full Text] [Related]
15. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
16. Post-ischemic administration of heparin-binding epidermal growth factor-like growth factor (HB-EGF) reduces infarct size and modifies neurogenesis after focal cerebral ischemia in the rat.
Jin K; Sun Y; Xie L; Childs J; Mao XO; Greenberg DA
J Cereb Blood Flow Metab; 2004 Apr; 24(4):399-408. PubMed ID: 15087709
[TBL] [Abstract][Full Text] [Related]
17. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.
Esneault E; Castagne V; Moser P; Bonny C; Bernaudin M
Neuroscience; 2008 Mar; 152(2):308-20. PubMed ID: 18262367
[TBL] [Abstract][Full Text] [Related]
18. The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.
Yang JP; Liu HJ; Wang ZL; Cheng SM; Cheng X; Xu GL; Liu XF
Neurosci Lett; 2009 Sep; 461(3):212-6. PubMed ID: 19559076
[TBL] [Abstract][Full Text] [Related]
19. Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia.
Baldauf K; Reymann KG
Brain Res; 2005 Sep; 1056(2):158-67. PubMed ID: 16125154
[TBL] [Abstract][Full Text] [Related]
20. Dimeric fibroblast growth factor-2 enhances functional recovery after focal cerebral ischemia.
Berry D; Ren J; Kwan CP; Sietsma DK; Sasisekharan R; Finklestein SP
Restor Neurol Neurosci; 2005; 23(3-4):251-6. PubMed ID: 16082081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
